Wednesday, July 8, 2026

pharma · Total Laryngectomy · Breast Cancer · ATOS

ATOSSA THERAPEUTICS

ATOSSA THERAPEUTICS clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Torrance, USA HQ
2019 Founded
36 Employees
Public company Type
ATOS · NYSE Ticker
Company details
Status
Public
HQ
Torrance, USA
Founded
2019
Employees
36
Programs
10
Drugs
5
Patents
8
Intelligence · Clinical Programs

ATOSSA THERAPEUTICS projects

2 ClinicalTrials.gov programs sponsored by ATOSSA THERAPEUTICS.

ATOSSA THERAPEUTICS has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. AT-301B

    ATOSSA THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  2. Provox Xtra HME

    ATOSSA THERAPEUTICS, INC.

    Total Laryngectomy

    phase 1 other completed

    1 trial

Frequently asked questions

How many clinical projects does ATOSSA THERAPEUTICS have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.